Showing 1 - 10 of 504
Persistent link: https://www.econbiz.de/10002783970
This paper uses an unbalanced panel data set for exporting firms from manufacturing industries in one German federal state, Lower Saxony, to investigate the micro-structure of the recent export boom. Looking at data for 1995/96 to 2001/02 it is demonstrated that a considerable number of plants...
Persistent link: https://www.econbiz.de/10012739311
Persistent link: https://www.econbiz.de/10006837287
Persistent link: https://www.econbiz.de/10006107487
Results of the model indicate that the health economic benefit of immunizing adults with PCV13 can be expected to outperform the sole use of PPV23, if the effectiveness of PCV13 is comparable to the effectiveness of PCV7. </AbstractSection> Copyright Kuhlmann et al.; licensee Springer. 2012
Persistent link: https://www.econbiz.de/10010998793
The relatively extensive range of measures used to promote the vaccination rate contrasts with insufficient knowledge about their efficacy and efficiency. There is an urgent requirement for more research here. </AbstractSection> Copyright Damm et al; licensee Springer. 2011
Persistent link: https://www.econbiz.de/10010998809
This study aims to identify the impact of a preterm birth on financial and emotional burden from the families' perspective. Additionally, a comprehensive schedule of recommendations for a sufficient evaluation of all aspects of burden is developed. Based on the results of a literature search...
Persistent link: https://www.econbiz.de/10010593416
The BURQOL-RD project is intended to develop a disease based model capable of quantifying the socio-economic burden and health-related quality of life for patients with rare diseases (RDs) and their caregivers in Europe. We described the methodology used to select a set of 10 RDs to be...
Persistent link: https://www.econbiz.de/10011048306
Background: The introduction of the conjugate vaccine PnC-7 implies that a pneumococcal vaccine is available, for the first time, which also gives children under the age of 2 years reliable protection against invasive pneumococcal infections and offers some protection against non-invasive...
Persistent link: https://www.econbiz.de/10005449263
Persistent link: https://www.econbiz.de/10008432667